数字生物标记:3PM 方法彻底改变慢性病管理 - EPMA 2024 立场

IF 6.5 2区 医学 Q1 Medicine
Ivica Smokovski, Nanette Steinle, Andrew Behnke, Sonu M. M. Bhaskar, Godfrey Grech, Kneginja Richter, Günter Niklewski, Colin Birkenbihl, Paolo Parini, Russell J. Andrews, Howard Bauchner, Olga Golubnitschaja
{"title":"数字生物标记:3PM 方法彻底改变慢性病管理 - EPMA 2024 立场","authors":"Ivica Smokovski, Nanette Steinle, Andrew Behnke, Sonu M. M. Bhaskar, Godfrey Grech, Kneginja Richter, Günter Niklewski, Colin Birkenbihl, Paolo Parini, Russell J. Andrews, Howard Bauchner, Olga Golubnitschaja","doi":"10.1007/s13167-024-00364-6","DOIUrl":null,"url":null,"abstract":"<p>Non-communicable chronic diseases (NCDs) have become a major global health concern. They constitute the leading cause of disabilities, increased morbidity, mortality, and socio-economic disasters worldwide.</p><p>Medical condition-specific digital biomarker (DB) panels have emerged as valuable tools to manage NCDs. DBs refer to the measurable and quantifiable physiological, behavioral, and environmental parameters collected for an individual through innovative digital health technologies, including wearables, smart devices, and medical sensors. By leveraging digital technologies, healthcare providers can gather real-time data and insights, enabling them to deliver more proactive and tailored interventions to individuals at risk and patients diagnosed with NCDs.</p><p>Continuous monitoring of relevant health parameters through wearable devices or smartphone applications allows patients and clinicians to track the progression of NCDs in real time. With the introduction of digital biomarker monitoring (DBM), a new quality of primary and secondary healthcare is being offered with promising opportunities for health risk assessment and protection against health-to-disease transitions in vulnerable sub-populations. DBM enables healthcare providers to take the most cost-effective targeted preventive measures, to detect disease developments early, and to introduce personalized interventions. Consequently, they benefit the quality of life (QoL) of affected individuals, healthcare economy, and society at large.</p><p>DBM is instrumental for the paradigm shift from reactive medical services to 3PM approach promoted by the European Association for Predictive, Preventive, and Personalized Medicine (EPMA) involving 3PM experts from 55 countries worldwide. This position manuscript consolidates multi-professional expertise in the area, demonstrating clinically relevant examples and providing the roadmap for implementing 3PM concepts facilitated through DBs.</p>","PeriodicalId":54292,"journal":{"name":"Epma Journal","volume":"42 1","pages":""},"PeriodicalIF":6.5000,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Digital biomarkers: 3PM approach revolutionizing chronic disease management — EPMA 2024 position\",\"authors\":\"Ivica Smokovski, Nanette Steinle, Andrew Behnke, Sonu M. M. Bhaskar, Godfrey Grech, Kneginja Richter, Günter Niklewski, Colin Birkenbihl, Paolo Parini, Russell J. Andrews, Howard Bauchner, Olga Golubnitschaja\",\"doi\":\"10.1007/s13167-024-00364-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Non-communicable chronic diseases (NCDs) have become a major global health concern. They constitute the leading cause of disabilities, increased morbidity, mortality, and socio-economic disasters worldwide.</p><p>Medical condition-specific digital biomarker (DB) panels have emerged as valuable tools to manage NCDs. DBs refer to the measurable and quantifiable physiological, behavioral, and environmental parameters collected for an individual through innovative digital health technologies, including wearables, smart devices, and medical sensors. By leveraging digital technologies, healthcare providers can gather real-time data and insights, enabling them to deliver more proactive and tailored interventions to individuals at risk and patients diagnosed with NCDs.</p><p>Continuous monitoring of relevant health parameters through wearable devices or smartphone applications allows patients and clinicians to track the progression of NCDs in real time. With the introduction of digital biomarker monitoring (DBM), a new quality of primary and secondary healthcare is being offered with promising opportunities for health risk assessment and protection against health-to-disease transitions in vulnerable sub-populations. DBM enables healthcare providers to take the most cost-effective targeted preventive measures, to detect disease developments early, and to introduce personalized interventions. Consequently, they benefit the quality of life (QoL) of affected individuals, healthcare economy, and society at large.</p><p>DBM is instrumental for the paradigm shift from reactive medical services to 3PM approach promoted by the European Association for Predictive, Preventive, and Personalized Medicine (EPMA) involving 3PM experts from 55 countries worldwide. This position manuscript consolidates multi-professional expertise in the area, demonstrating clinically relevant examples and providing the roadmap for implementing 3PM concepts facilitated through DBs.</p>\",\"PeriodicalId\":54292,\"journal\":{\"name\":\"Epma Journal\",\"volume\":\"42 1\",\"pages\":\"\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2024-05-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Epma Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s13167-024-00364-6\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epma Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13167-024-00364-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

非传染性慢性疾病(NCDs)已成为全球关注的主要健康问题。针对特定医疗条件的数字生物标志物(DB)面板已成为管理非传染性慢性疾病的重要工具。数字生物标记指的是通过创新的数字健康技术(包括可穿戴设备、智能设备和医疗传感器)收集的个人可测量和量化的生理、行为和环境参数。通过利用数字技术,医疗服务提供者可以收集实时数据和洞察力,从而为高危人群和确诊为非传染性疾病的患者提供更加积极主动和量身定制的干预措施。通过可穿戴设备或智能手机应用程序对相关健康参数进行持续监测,患者和临床医生可以实时跟踪非传染性疾病的进展情况。随着数字生物标记物监测(DBM)的引入,初级和中级医疗保健的质量得到了新的提升,为健康风险评估和保护弱势亚人群免受从健康到疾病的转变带来了大好机会。DBM 使医疗服务提供者能够采取最具成本效益的针对性预防措施,及早发现疾病的发展并采取个性化干预措施。欧洲预测、预防和个性化医学协会(EPMA)由来自全球 55 个国家的 3PM 专家组成,该协会提倡从被动医疗服务向 3PM 方法转变,而 DBM 对这一转变至关重要。本职位手稿整合了该领域的多学科专业知识,展示了与临床相关的实例,并提供了通过 DBs 实施 3PM 概念的路线图。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Digital biomarkers: 3PM approach revolutionizing chronic disease management — EPMA 2024 position

Digital biomarkers: 3PM approach revolutionizing chronic disease management — EPMA 2024 position

Non-communicable chronic diseases (NCDs) have become a major global health concern. They constitute the leading cause of disabilities, increased morbidity, mortality, and socio-economic disasters worldwide.

Medical condition-specific digital biomarker (DB) panels have emerged as valuable tools to manage NCDs. DBs refer to the measurable and quantifiable physiological, behavioral, and environmental parameters collected for an individual through innovative digital health technologies, including wearables, smart devices, and medical sensors. By leveraging digital technologies, healthcare providers can gather real-time data and insights, enabling them to deliver more proactive and tailored interventions to individuals at risk and patients diagnosed with NCDs.

Continuous monitoring of relevant health parameters through wearable devices or smartphone applications allows patients and clinicians to track the progression of NCDs in real time. With the introduction of digital biomarker monitoring (DBM), a new quality of primary and secondary healthcare is being offered with promising opportunities for health risk assessment and protection against health-to-disease transitions in vulnerable sub-populations. DBM enables healthcare providers to take the most cost-effective targeted preventive measures, to detect disease developments early, and to introduce personalized interventions. Consequently, they benefit the quality of life (QoL) of affected individuals, healthcare economy, and society at large.

DBM is instrumental for the paradigm shift from reactive medical services to 3PM approach promoted by the European Association for Predictive, Preventive, and Personalized Medicine (EPMA) involving 3PM experts from 55 countries worldwide. This position manuscript consolidates multi-professional expertise in the area, demonstrating clinically relevant examples and providing the roadmap for implementing 3PM concepts facilitated through DBs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Epma Journal
Epma Journal Medicine-Biochemistry (medical)
CiteScore
11.30
自引率
23.10%
发文量
0
期刊介绍: PMA Journal is a journal of predictive, preventive and personalized medicine (PPPM). The journal provides expert viewpoints and research on medical innovations and advanced healthcare using predictive diagnostics, targeted preventive measures and personalized patient treatments. The journal is indexed by PubMed, Embase and Scopus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信